15/04/2014 - 15:35
LONDON – Obeticholic acid significantly reduced key liver enzyme and bilirubin levels in patients with primary biliary cirrhosis in a phase III trial.
Results of <link...
Field of Interest: Gastroentero...
Categories:
News Feed: Internal Medicine News - Gastroenterology